Urology
Volume 75, Issue 6 , Pages 1283-1284 , June 2010

Reply

  • Andrew H. Feifer, M.D.

      Affiliations

    • Department of Pathology, McGill University, Montreal, Quebec, Canada
    • ,
  • Wassim Kassouf, M.D., F.R.C.S.(C)

      Affiliations

    • Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada

References 

  1. Theodorou C, Goulandris N, Kotzia-Theodorou E, et al. Sensitivity of exfoliative cytology in bladder cancer using the divided one-urine specimen examination. Br J Urol. 1984;56:48
  2. Gupta NP, Sharma N, Kumar R. Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder. Urology. 2009;73:592
  3. Roland SI, Marshall VF. The reliability of the Papanicolaou technique when cancer cells are found in the urine. Surg Forum. 1957;7:684
  4. Murphy WM. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol. 1990;21:886
  5. Trivedi D, Messing EM. Commentary: the role of cytologic analysis of voided urine in the work-up of asymptomatic microhematuria. BMC Urol. 2009;9:13

PII: S0090-4295(09)02949-5

doi: 10.1016/j.urology.2009.11.037

Urology
Volume 75, Issue 6 , Pages 1283-1284 , June 2010

Article Tools